The Impact of Smoking on Clinical Outcomes after Percutaneous Coronary Intervention in Women Compared to Men

Table 4

MACE incidence in mid-tem, long term, and total between smokers and nonsmokers.

		Smokers (n = 847)	Nonsmokers (n = 952)
Mid-term MACE	Male	14/634 (2.2%)	7/467 (1.5%)	0.395
	Female	8/213 (3.8%)	4/485 (1.0%)	0.028
		0.219	0.518
Long-term MACE	Male	37/565 (6.5%)	23/403 (5.7%)	0.592
	Female	21/188 (11.2%)	16/434 (3.7%)	<0.001
		0.040	0.166
MACE	Male	51/634 (8.0%)	30/467 (6.4%)	0.309
	Female	29/213 (13.6%)	20/485 (4.1%)	<0.001
		0.016	0.112

Mid-term: 24 hours up to 6 months after index PCI, long term: 6 months after index PCI, MACE: major adverse cardiac event, and n = number. Bold values imply significant differences.